KFF Health Information and Trust Polling Dashboard

Key insights and trends from KFF’s polling on Health Information and Trust

Last Updated:

June 30, 2026

Trusted Sources of Health Information

Who the Public Trusts For Health Information

Copy link to Who the Public Trusts For Health Information

Doctors and other health care providers are the public’s most trusted source of health information, while trust in government health agencies and officials is much more divided. A large majority of adults express at least “a fair amount” of trust in their doctor for reliable information about health issues, while half say they trust the CDC or FDA and fewer than half express trust in their state government officials, HHS Secretary Robert F. Kennedy, Jr., or President Trump.

U.S. Adults Are Most Trusting of Their Own Doctors for Health Information; Fewer Trust Government Health Authorities (Stacked Bars)

Partisanship shapes who the public trusts for health information, especially when it comes to Secretary Kennedy and President Trump. Two-thirds of Republicans, rising to three-quarters among MAGA-supporting Republicans, say they trust Secretary Kennedy and President Trump for reliable health information compared to one-third or fewer independents and Democrats who say the same. On the other hand, Democrats are somewhat more likely than Republicans to trust their state officials for health information, while similar shares of Democrats and Republicans say they trust the CDC or FDA. Individual health care providers are the most-trusted source for health information across partisanship.

Across demographic groups – including age, gender, race and ethnicity, and education – health care providers remain the most trusted source of health information. For other health information sources, trust does not differ consistently across most of these groups, but White adults and those without a college degree are more likely than their peers to express trust in Secretary Kennedy and President Trump for health information.

Confidence in Federal Health Agencies

Copy link to Confidence in Federal Health Agencies

Most of the public lacks confidence in agencies like the CDC or FDA to carry out many of their core responsibilities. While Democrats are somewhat more likely than Republicans to have at least “some confidence” in government health agencies to ensure vaccine safety and effectiveness and make recommendations about the childhood vaccine schedule, fewer than half across partisans have confidence in these agencies to make decisions based on science. For more information, see KFF’s January 2026 Tracking Poll on Health Information and Trust.

Fewer Than Half the Public and Partisans Are Confident in Government Health Agencies To Make Decisions Based on Science (Bar Chart)

Less than half of the public and partisans express at least “some confidence” in the CDC, FDA, or EPA to act independently without outside interference. Democrats are somewhat more likely to say they have confidence in the CDC to act independently, with almost half expressing confidence. On the other hand, four in ten or fewer adults and partisans express confidence in the independence of the FDA or the EPA. For more information, see KFF’s April 2026 Health Tracking Poll.

Fewer Than Half the Public Have Confidence in the CDC, FDA, or EPA To Act Independently Without Interference from Outside Interests (Split Bars)

Trends in Trust of Government Health Agencies and Officials

Copy link to Trends in Trust of Government Health Agencies and Officials

At the onset of the COVID-19 pandemic, there were high levels of bipartisan trust in information about the new virus from the U.S. Centers for Disease Control and Prevention (CDC). Trust in the agency for information about COVID-19 vaccines, and vaccines more generally, subsequently declined amid widening partisan divisions and large drops in Republican trust. Democratic trust in the agency has since declined significantly following President Trump’s reelection and the confirmation of Robert F. Kennedy Jr. as HHS Secretary. Amid these partisan shifts, half of the public now express trust in the CDC for reliable vaccine information. Keep scrolling to see trends among the public and partisans.  

KFF polling has found trust in vaccine information from other health agencies and officials has also declined amid partisan divisions since 2020, including for the U.S. Food and Drug Administration (FDA), state government officials, and local public health departments. 

Who Parents Trust for Childhood Vaccine Information

Copy link to Who Parents Trust for Childhood Vaccine Information

Among parents of children under age 18, pediatricians are the most trusted source of reliable vaccine information. Smaller shares, but still majorities, also trust their local public health department, the CDC, and the FDA. Over half of parents trust their friends and family for vaccine information, while far fewer express trust in Robert F. Kennedy Jr., pharmaceutical companies, or health and wellness influencers. As with the public overall, partisanship plays a role in who parents trust for vaccine information. For more information, see the KFF/Washington Post Survey of Parents.

Among parents, Secretary Kennedy garners trust on vaccines from a majority of Republican supporters of the Make America Great Again, or MAGA, movement (18% of all parents) and supporters of the Make America Healthy Again, or MAHA, movement (38% of all parents). While slim majorities of these MAGA and MAHA parents trust Kennedy for vaccine information, larger shares express trust in their child’s pediatrician.

News, Social Media, and AI

Use and Trust of News Sources for Health Information

Copy link to Use and Trust of News Sources for Health Information

KFF’s Health Misinformation Tracking Poll Pilot measured the public’s consumption of a variety of television, print, radio, and digital news media sources as well as their trust in these sources for information about health issues. Overall, few adults both regularly consume most news sources and trust them a lot for information on health issues, with local and network television news topping the list. Nearly a quarter (23%) of adults say they regularly watch their local TV station and would trust it “a lot” for health information, while a similar share (21%) say the same about national network news. Other news sources, including NPR, CNN, Fox News, local newspapers, The New York Times, digital news aggregators, and MSNBC have trusting audiences that make up between one in ten and one in six of the overall public.    

Stacked bar chart showing percent who say they would trust information about health issues "a lot" and "a little" if they were reported by specific news sources.

Social Media Use for Health Information

Copy link to Social Media Use for Health Information

About three in ten adults say they use social media to find health information and advice “at least monthly,” including larger shares of younger adults, Black and Hispanic adults, lower income adults, and those with lower educational attainment. For more information see KFF’s June 2026 Tracking Poll on Health Information and Trust.

Stacked bar chart showing how often U.S. adults report using social media. Results shown by age gender, race/ethnicity, and party ID.

About one-third of adults who use social media for health information say a “major reason” they turned to social media for health advice was because they wanted to learn from people with similar experiences or because they wanted immediate information or support. About one in six users cite difficulty accessing or affording health care as a major reason.  

Learning From People Who Share Similar Health Experiences Is a Top Reason Adults Use Social Media for Health Information and Advice (Stacked Bars)

Similar shares of adults who use social media for health information or use AI chatbots for health information cite difficulties accessing or affording health care as major reasons they turned to these tools for health advice. These reasons are more commonly cited among lower income social media and AI users. For additional information on use of AI for health information, see AI and Health Information section below.

Similar Shares of Adults Who Use Social Media or AI for Health Information Say Not Having a Regular Provider Was a Reason for Using These Tools (Stacked Bars)
Among Adults Who Use Social Media or AI For Health Information, Those With Lower Incomes Are More Likely To Cite Access and Affordability Issues as a Major Reason (Split Bars)

While fewer than half of the public report actively using social media at least monthly to find health information and advice, larger shares report being exposed to such information in the past month, with majorities saying they have recently seen content related to weight loss, diet, or nutrition and mental health.

While four in ten social media users say they regularly get information about news and politics from social media influencers, far fewer (15%) say they turn to influencers for health information and advice. Younger adults, Black adults, and more frequent social media users are more likely than their peers to say they rely on influencers for health information. For more information on the relative impact of influencers on the public and health policy debates, see KFF CEO Drew Altman’s column.

Split bar chart showing the share of U.S. adults who report regularly getting health information and advice and news about politics from influencers on social media. Results by age gender, party ID, and social media use.

Trust in Social Media for Health Information

Copy link to Trust in Social Media for Health Information

Across different social media platforms, fewer than half of users say they find at least “some” of the health information they see on these platforms to be trustworthy. Younger users tend to be more trusting than older users of health content on certain platforms including TikTok, YouTube, Instagram, and Reddit.

AI and Health Information

Copy link to AI and Health Information

About a third (32%) of the public reports turning to AI chatbots for health information and advice in the past year – rivaling social media as a health information source, but less common than reliance on health care providers or internet search engines (where they may be encountering AI generated results, even if they are not looking for them). The share of adults using AI for health information includes three in ten who say they’ve used these chatbots in the past year for information or advice about their physical health, and one in six who’ve used them for mental health information or advice. For more information, see KFF’s March 2026 Tracking Poll on Health Information and Trust.

Split bar chart showing percent who have sought information or advice about their physical or mental health from specific sources in the past year.

Larger shares of younger adults report turning to AI for either physical health or mental health information in the past year. When it comes to mental health advice, uninsured adults and Black and Hispanic adults are more likely than insured adults and White adults to have turned to AI.

People report using AI for either physical health or mental health information in a variety of ways, most commonly to look up symptoms or general information about health conditions. Fewer say they used AI to help make decisions about whether to seek medical care for either physical or mental health concerns.

Bar chart showing percent who say they have used artificial intelligence tools for information and advice about their physical health in the past year, and whether they have used it for specific reasons.

The most common reason people cite for turning to AI for health advice is wanting quick or immediate support. Many also cite wanting to look up information before seeing a provider or feeling more comfortable looking up health questions privately. One in five cite health care access or affordability issues as major reasons for turning to AI for health questions, including larger shares of younger adults and those with lower household incomes

Among the public overall, few adults say they trust AI tools to provide reliable information about health, but most adults who have used AI for health information and advice say they trust these chatbots to provide reliable health information.

Split bar chart showing trust in AI tools to provide reliable information about health and mental health respectively. Results shown by total adults and by use of AI for different types of health information.

False or Unproven Health Claims

Awareness and Belief in False or Unproven Health Claims

Copy link to Awareness and Belief in False or Unproven Health Claims

Exposure to health misinformation is often widespread, but relatively small shares of the public express certainty that many false or unproven claims are true. In fact, at least half of the public fall in a “malleable middle,” saying these claims are either “probably true” or “probably false.” The public’s uncertainty around false or unproven health claims related to COVID-19 , vaccines , measles  and the purported causal link between Tylenol and autism presents an opportunity for interventions to clear up confusion and deliver accurate information.

Measuring Exposure

Copy link to Measuring Exposure

KFF polls have measured exposure to a wide array of false, misleading, and unproven health claims since 2023. Exposure varies widely depending on the topic and prominence of news coverage of the claim. The most widely heard of those tested in KFF polls is that taking Tylenol during pregnancy increases the risk of a child developing autism, a claim cited by President Trump in a widely covered September 2025 press conference.

The Malleable Middle

Copy link to The Malleable Middle

Across an array of false or unproven health claims measured in KFF surveys, few adults are certain these claims are “definitely true” while much larger shares say they are “definitely false.” For most claims, at least half express uncertainty, falling into the malleable middle and saying the claims are either “probably true” or “probably false.” Six recent false claims measured in 2026 and 2025 KFF surveys are shown below.

While Few Adults Think False or Unproven Health Claims Are Definitely True, Many Express Uncertainty (Stacked Bars)

Typology of Belief Across Vaccine Myths

Copy link to Typology of Belief Across Vaccine Myths

While KFF polling has consistently found that much of the public falls in the “malleable middle” when it comes to a wide array of false health claims, there are nuances within this group that can be examined by looking at patterns of belief across multiple myths. KFF’s June 2026 Tracking Poll on Health Information and Trust identified five groups based off patterns of belief across four common vaccine myths:

KFF polling has measured exposure to and belief in false or unproven claims across a wide array of topics. For information on belief in additional claims about COVID-19, reproductive health, and gun violence, see KFF’s Health Misinformation Tracking Poll Pilot.  For information on additional false claims related to COVID-19, see KFF’s May 2022, and October 2021 COVID-19 Vaccine Monitors.

Belief in False or Unproven Health Claims

Copy link to Belief in False or Unproven Health Claims

KFF polling has found partisanship and education play a substantial role in belief of false or unproven health claims about vaccines, COVID-19 and measles. Republicans and adults without a college degree are consistently more likely than Democrats and college educated adults, respectively, to believe or lean towards believing vaccine-related myths. For more information, see KFF's June 2026 Tracking Poll on Health Information and Trust.

Beyond partisanship and education, belief in common vaccine myths sometimes varies by age and race and ethnicity. Larger shares of adults ages 30-49 compared to older adults say false claims about vaccines are either definitely or probably true, as do Black adults compared to White adults. Hispanic adults are more likely than White adults to endorse two false claims about the measles vaccines. These differences show that susceptibility to health misinformation among some groups can vary depending on the topic, which may reflect different information channels relied upon by these groups (see social media and news sources sections for more information).

Adults who frequently use social media or artificial intelligence (AI) tools for health information are more likely to say several false claims about vaccines are definitely or probably true, as are those who lack a trusted health care provider compared to those who have a provider they trust to answer questions about their health.

Appendix For False or Unproven Health Claims

Copy link to Appendix For False or Unproven Health Claims

KFF polling has sought to examine the public’s exposure to and belief in a wide array of false or unproven health claims. Many of the false or unproven claims measured in KFF surveys have been amplified by or directly made by government officials, while others have been more nebulously shared and spread in public media over the years. Below is a list of sources to document these claims’ inaccuracy.

Table

Vaccine Attitudes

Views on Vaccine Safety Among the Public

Copy link to Views on Vaccine Safety Among the Public

Most U.S. adults, including majorities across partisans, express confidence in the safety of many routine vaccines for children, including MMR, polio, and hepatitis B. Similarly, large majorities of adults ages 50 and over are confident that vaccines for pneumonia and shingles are safe. Views on the safety of COVID-19 and flu vaccines for both adults and children are more divided, with large shares of Democrats expressing confidence compared with smaller shares of Republicans. For more information, see KFF’s June 2026, January 2026 and April 2025 Tracking Polls on Health Information and Trust.

Parents’ Vaccine Attitudes and Behavior

Copy link to Parents’ Vaccine Attitudes and Behavior

In summer 2025, large majorities of parents expressed confidence in the safety of childhood vaccines for polio and measles, mumps, and rubella (MMR), but parents’ views on the safety of flu and COVID-19 vaccines were more polarized. About two-thirds of parents say the flu vaccines are safe for children, while fewer than half say the same about COVID-19 vaccines, with divisions along partisan lines. Beyond partisanship, parents who support the Make America Healthy Again (MAHA) movement (38% of parents), Black parents and parents under age 35 are less likely than their peers to be confident that many routine vaccines are safe for children. For more information, see the KFF/Washington Post Survey of Parents.

Majorities of Parents Are Confident in the Safety of Childhood Polio and MMR Vaccines, but Vaccines for COVID-19 and the Flu Are Divisive (Split Bars)

Most parents report keeping their children up to date on childhood vaccines, but about one in six say they have ever skipped or delayed at least one childhood vaccine for any of their children (excluding seasonal vaccines like flu and COVID-19). Despite strong uptake, many parents express skepticism towards vaccine safety testing and the number of vaccines recommended by the CDC (this survey was fielded prior to recent changes to the childhood vaccine schedule announced by HHS in January 2026). Younger parents and those who identify as Republicans are more likely than their counterparts to endorse vaccine-skeptical attitudes and to report skipping vaccines for their own children. For more information, see the KFF/Washington Post Survey of Parents.

Split bar chart showing percent who say specific false claims about vaccines and diseases are true. Results shown by total parents, parents by vaccine choice, party identification, and support for MAGA.

Parents who skip or delay recommended vaccines for their children are about twice as likely as parents who keep their children up to date on vaccines to believe or lean toward believing false claims about the measles and COVID-19 vaccines, underscoring how false health claims may shape parents’ decisions. For more information, see KFF's June 2026 Tracking Poll on Health Information and Trust.

Split bar chart showing share of U.S. adults who say they believe about each of three false claims related to measles.

mRNA Vaccine Safety

Copy link to mRNA Vaccine Safety

COVID-19 vaccines and some other vaccines currently under development rely on a vaccine technology known as messenger-RNA (mRNA), which has long been the subject of misinformation. While few adults view mRNA technology as unsafe, the technology remains obscure to much of the public, with about half saying they don’t know enough to say. For more information, see KFF’s April 2025 Tracking Poll on Health Information and Trust.

Stacked bar chart showing how safe U.S. adults, by partisanship, think mRNA technology in vaccines is.

The Business of Health with Chip Kahn

AI: Show Me the Outcomes

June 30, 2026

Video

Audio

About this Episode


Episode 10, AI Series: Chip talks with Dr. Toyin Ajayi, co-founder and CEO of Cityblock Health, which delivers value-based care to more than 100,000 Medicaid and dual-eligible members across ten states, many of them people of color managing chronic conditions. Ajayi makes a pointed case: Roughly 60 percent of health care AI investment goes to billing, coding, and risk adjustment — making sure someone gets paid — while only a fraction goes to delivering care. If we continue to concentrate AI there, she warns, it will drive up cost without improving outcomes. She says there is a better way — AI built for care can lower costs by improving care for those hardest to reach. She and Chip discuss what that looks like and how Cityblock is using AI now to improve care and the patient experience for its members.

The Host


Headshot photo of Chip Kahn wearing a navy blue suit with a red tie, red pendant on lapel, and glasses.

Sr. Visiting Fellow

Charles N. Kahn III is a senior visiting fellow at KFF. He is also a visiting senior fellow at the American Enterprise Institute and a nonresident senior scholar at the University of Southern California’s Schaeffer Center for Health Policy & Economics. He serves as co-chair of the international Future of Health collaborative.

Guest


Co-founder and Chief Executive Officer, Cityblock Health

Dr. Toyin Ajayi is a Board-certified Family Medicine physician and CEO of Cityblock, a value-based healthcare provider for Medicaid and dually eligible beneficiaries. Prior to Cityblock, she served as Chief Medical Officer of Commonwealth Care Alliance, an integrated health plan and care delivery system for Medicare and Medicaid beneficiaries. Dr. Ajayi serves on the Board of Directors of Evolent Health and Foodsmart and is a co-founder of Coalition Partners. She’s an Aspen Institute Henry Crown Fellow and a member of the National Academy of Medicine. She’s been named to Inc.’s Female Founders 500 list, TIME100 Next, Modern Healthcare’s Top Women Leaders in Healthcare, and the STATUS List.

Dr. Ajayi received her undergraduate degree from Stanford University, an MPhil from the University of Cambridge, her medical degree, with Distinction in Clinical Practice, from King’s College London School of Medicine, and in 2024 was awarded an honorary Doctorate of Science from Georgetown University. Board certified in Family Medicine, Dr. Ajayi completed her residency training at Boston Medical Center and practiced as a hospitalist and primary care provider with a focus on patients with chronic, complex and end-of-life needs.


SERIES

This weekly podcast features insightful conversations between host Chip Kahn and his guests, who discuss the business of health care, connecting the dots between the health care business, policy, and patients.

The podcast’s first series on AI in health care illuminates how AI is changing health care, and features guests who are deploying this technology, managing its consequences, and designing policy around it.

News Release

Poll: People Without a Trusted Health Care Provider Are More Likely to Endorse Vaccine Myths, As Are Those Who Often Use Social Media or AI for Health Information

While More People Identify Vaccine Myths as “Definitely False” than “Definitely True,” At Least Half Are Uncertain About What to Believe

Published: Jun 30, 2026

People who don’t have a trusted health care provider are more likely than people with one to believe or lean toward believing several common myths about vaccines, a new KFF Tracking Poll on Health Information and Trust reveals. Similarly, people who use social media or artificial intelligence (AI) chatbots at least weekly for health information are more likely than those who don’t to endorse these false vaccine claims.

One example: Among adults who say they do not have a doctor or other health provider they trust to answer questions about their health, about 4 in 10 (39%) incorrectly believe that it is either “definitely” or “probably true” that MMR vaccines have been proven to cause autism in children, compared to a quarter (24%) among those who say they have a trusted provider.

Similarly, more than a third of people who report using social media (37%) or AI chatbots (35%) at least weekly for health information incorrectly say this myth is true, about twice the share among those who never use social media (16%) or AI (20%) for health information.

The poll finds a similar pattern for most of the other vaccine myths tested for people without a trusted doctor as well as for people who frequently use social media or AI for health information. The differences remain significant even when controlling for other factors such as age, race and ethnicity, education, partisanship, and insurance status.

Exposure to each of these false claims has been fairly steady in KFF polls over the past several years, though the share who report hearing the myth that mRNA vaccines can alter a person’s DNA dropped by 9 percentage points since April 2025 (from 45% to 36%). Exposure to the myth that measles vaccines are more dangerous than measles rose between 2024 and 2025, but has remained steady since then (29% now).

Across the four false vaccines claims, far more people say the claims are “definitely false” than say they are “definitely true,” but at least half of the public is less certain what to believe, falling into the malleable middle and saying each of these claims are either “probably true” or “probably false.”

While many parents who skip or delay recommended vaccines for their children express uncertainty over vaccine myths, they are also about twice as likely as parents who keep their children up to date on vaccines to believe or lean toward believing false claims about the measles and COVID-19 vaccines.

The pattern is true for each of the four false claims: that MMR vaccines cause autism in children (57%  among those who delay or skip vaccines v. 30% among those who stay up to date), that more people died from COVID-19 vaccines than the virus itself (55% v. 29%), that mRNA vaccines alter DNA (52% v. 23%), and that measles vaccines are more dangerous than measles (43% v. 18%). This relationship remains significant even when controlling for factors like age, education, and partisanship.

The poll also includes a new analysis that identifies patterns of belief across the four false claims and sorts them into a new belief typology. A small share (8%) are consistent or leaned myth believers (saying all four claims are either “probably” or “definitely true”) and just over half (55%) are consistent or leaned myth deniers (saying all four claims are either “probably” or “definitely false”). About 3 in 10 (31%) are in the mixed middle, providing a range of true and false answers and lacking certainty on at least half of the claims.

Designed and analyzed by public opinion researchers at KFF, this survey was conducted May 7-31, 2026, online and by telephone among a nationally representative sample of 2,480 U.S. adults in English and in Spanish. The margin of sampling error is plus or minus three percentage points for the full sample. For results based on other subgroups, the margin of sampling error may be higher.

Poll Finding

KFF Tracking Poll on Health Information and Trust: Update on Common Vaccine Myths

Published: Jun 30, 2026

Findings

Key Takeaways

  • With childhood vaccination rates in the U.S. continuing to decline as measles cases rise across the U.S., KFF’s latest Tracking Poll on Health Information and Trust shows that several commonly circulated vaccine myths remain pervasive among the public. Many adults say they have heard false claims about the measles and COVID-19 vaccines, including that the measles, mumps, and rubella (MMR) vaccines have been proven to cause autism in children (66%), that more people have died from the COVID-19 vaccines than the virus (46%), that mRNA vaccines can alter DNA (36%), or that measles vaccines are more dangerous than measles itself (29%).
  • While many have heard of these myths, smaller shares are convinced they are true. Fewer than one in ten adults express ardent belief in each myth, while larger shares (between 31% and 44%) say each are “definitely false” and at least half fall in the “malleable middle,” saying each of these claims is either “probably true” or “probably false.”
  • Adults who have a relationship with a trusted health care provider are less likely than those who don’t have such a relationship to believe or lean toward believing vaccine falsehoods. For instance, nearly half (46%) of adults who say they do not have a health care provider they trust to answer questions about their health say it is “probably” or “definitely true” that more people have died from COVID-19 vaccines than from the virus, which is nearly twice the share among those with a trusted provider (24%). While younger adults, Hispanic adults, and uninsured adults are more likely than their counterparts to say they don’t have a trusted provider, the connection between lacking a trusted provider and belief in vaccine myths holds even when controlling for factors like age, race and ethnicity, education, partisanship, and insurance coverage.
  • Those who use social media and artificial intelligence (AI) chatbots for health information are also more likely to endorse many of these vaccine myths. For example, adults who use social media for health information at least weekly are more than twice as likely as those who don’t use social media for health to say the myth linking MMR vaccines to autism is “probably” or “definitely true” (37% v. 16%). Use of artificial intelligence (AI) for health information is also correlated with views on some of these myths, with adults who regularly use AI for health information more likely than non-users to believe or lean toward believing myths about the MMR and mRNA vaccines. While younger adults, Black and Hispanic adults, and those without a college degree are all more likely to use to social media for health information, the connection between frequent use and belief in vaccine myths holds even when controlling for factors like age, race and ethnicity, education, and partisanship.
  • Parents’ views on vaccine myths are also correlated with their decisions about childhood vaccinations. Parents who report skipping or delaying recommended childhood vaccines are consistently at least 25 percentage points more likely than those who keep their children up-to-date to say vaccine myths are “definitely” or “probably true,” including the false claims that MMR vaccines cause autism in children (57% v. 30%), that more people died from COVID-19 vaccines than the virus itself (55% v. 29%), that mRNA vaccines alter DNA (52% v. 23%), and that measles vaccines are more dangerous than measles (43% v. 18%). This relationship remains significant even when controlling for factors like age, education, and partisanship.
  • When looking at patterns of belief across the four false vaccine claims, a new analysis shows that some adults are consistent or leaned myth believers (8% who say all four claims are either “probably” or “definitely true”), or myth deniers (55% who deny all four claims, saying they are either “probably” or “definitely false”). At the same time, about three in ten (31%) fall in a “mixed middle” group, providing a range of true and false answers across the four vaccine myths and lacking certainty on at least half of the false claims. This group may be an important focus for those looking to counter vaccine misinformation and dispel confusion. Black adults, Hispanic adults, Republicans, younger adults, and those without a college degree are all more likely than their counterparts to fall into this “mixed middle” group, as are individuals who go to social media or AI for health information. Notably, nearly half of parents who report skipping or delaying recommended vaccines for their children fall in the “mixed middle,” indicating that these parents’ decisions may be driven, at least in part, by uncertainty and confusion.

Exposure to Common Vaccine Myths

The latest KFF Tracking Poll on Health Information and Trust examines the pervasiveness of several commonly circulated vaccine myths. These false or unproven claims about vaccines have remained persistent in terms of exposure over the past several years, with little change to the share of the public have heard most of these myths.

The false claim that MMR vaccines have been proven to cause autism in children – a myth associated with a since retracted study from the 1990s – remains one of the most widely heard vaccine myths, with two-thirds of adults saying they have heard or read this. Nearly half (46%) of adults say they have heard the false claim that more people have died from the COVID-19 vaccines than the virus itself, and about one third of adults (36%) say they have heard the myth that mRNA vaccines can change your DNA (mRNA is a vaccine technology utilized by some COVID-19 vaccines and others under development). About three in ten adults (29%) say they have heard the false claim that measles vaccines are more dangerous than measles infections.

Exposure to each of these false claims has been fairly steady in KFF polls over the past several years, though the share who report hearing the myth that mRNA vaccines can alter a person’s DNA dropped by 9 percentage points since April 2025 (from 45% to 36%). Exposure to the myth that measles vaccines are more dangerous than measles rose between 2024 and 2025, but has remained steady since then.

Figure 1

Uncertainty Surrounding False Vaccine Claims

While many report having heard some false claims about vaccines, very few adults are ardent believers in these myths, with larger shares (but fewer than half) stating the myths are “definitely false.” At the same time, and consistent with past KFF polling, at least half of adults fall into the “malleable middle” across the myths, expressing some uncertainty and saying these vaccine myths are either “probably true” or “probably false.” Across these four vaccine falsehoods, most parents fall into the malleable middle, expressing some uncertainty for each claim.

Stacked bar chart showing the share of the public who believe four false vaccine claims are definitely true, probably true, probably false, or definitely false.

Over time, the share who fall in the “malleable middle” for these vaccine myths has been relatively stable, with at least half saying each is either “probably true” or “probably false.” At the same time, there have been some minor shifts in the share who view some of these myths as “definitely false” over the past few years, underscoring how the public’s willingness to endorse vaccine falsehoods is not completely static. Somewhat larger shares of adults now say it is “definitely false” that mRNA vaccines can change your DNA (31% now v. 24% in April 2025), and that measles vaccines are more dangerous than getting infected with measles (44% now v. 38% in March 2024). Conversely, the share of adults who think it is “definitely false” that more people have died from COVID-19 vaccines than from the virus has declined (39% now compared to 47% in June 2023) alongside a 5-percentage point jump in the share who say this myth is “probably true.” There have been no notable changes in views of the long-standing myth that MMR vaccines cause autism.

Stacked bar chart showing how belief in four false vaccine claims has changed over time, from June 2023 to June 2026.

Belief in Vaccine Myths is Tied to Lacking a Trusted Health Care Provider And Use of Social Media and AI For Health Information

Previous KFF polls have shown that health care providers are the most trusted source of health information among the public, and this latest poll shows that individuals who have a trusted provider are less likely than those without a trusted provider to endorse vaccine-related myths. For example, among adults who say they do not have a doctor or health care provider they trust to answer questions about their health (16% of all adults), nearly half (46%) say it is either “definitely” or “probably true” that more people have died from COVID-19 vaccines than from the COVID-19 virus, compared to a quarter (24%) among those who say they have a trusted health care provider.

Unsurprisingly, adults who say they do not have a trusted health care provider to answer their health questions are much more likely to be uninsured than those who have a provider they trust (36% v. 7%). At the same time, lacking a trusted provider could be related to low trust in providers and doctors more broadly and not necessarily related to health care access. Across demographics, adults under age 50, LGBT adults, and Hispanic adults are all more likely than their counterparts to say they don’t have a provider they trust to answer questions about their health. However, the connection between not having a trusted provider and belief in vaccine myths remains significant even when controlling for factors like age, race and ethnicity, education, partisanship, and insurance coverage.

Grouped bar chart showing the percentage of adults who believe four false vaccine claims are definitely or probably true, comparing adults with and without a trusted health care provider.

Frequent health information-seeking on social media and via artificial intelligence (AI) chatbots is also tied to a tendency to believe vaccine myths. Adults who say they use social media for health information and advice at least weekly (26% of all adults) are more likely than those who never use social media for health to say each false vaccine claim is “probably” or “definitely true.” Similarly, adults who report using AI tools or chatbots at least weekly for health advice (20% of all adults) are more likely than those who never use these chatbots to endorse myths about the measles vaccines and mRNA vaccines. For example, the share who say it is “probably” or “definitely true” that MMR vaccines have been proven to cause autism is higher among adults who seek health advice at least weekly from social media (37%) or AI (35%) compared to those who never use social media (16%) or AI (20%) for health advice.

The relationship between belief in vaccine myths and use of social media or AI for health information continues to be significant even when controlling for factors like age, race and ethnicity, education, and partisanship.

Bar chart showing the percentage of adults who believe four false vaccine claims are definitely or probably true, broken down by how often they use social media and AI tools for health information.

Parents who skip or delay recommended vaccines for their children are about twice as likely as parents who keep their children up to date on vaccines to believe or lean toward believing false claims about the measles and COVID-19 vaccines, underscoring how false health claims may shape parents’ decisions.

Overall, at least three in ten parents say it is “probably” or “definitely true” that MMR vaccines have been proven to cause autism in children (36%), that more people have died from COVID-19 vaccines than the virus (35%), or that mRNA vaccines can alter DNA (29%). About one in four (23%) parents believe or lean toward believing the myth that measles vaccines are more dangerous than measles.

The tendency to endorse these false vaccine claims, however, rises substantially among parents who report not keeping their children up to date on recommended vaccines. Six in ten (57%) parents who report having skipped or delayed recommended childhood vaccines (excluding seasonal vaccines for COVID-19 and flu), say it is either “definitely true” or “probably true” that the MMR vaccines have been proven to cause autism in children, while around half believe or lean toward believing that the COVID-19 vaccines killed more people than the virus (55%), or that mRNA vaccines alter DNA (52%). About four in ten (43%) parents who skipped or delayed childhood vaccines say it is true that the measles vaccines are more dangerous than measles itself. Each of these shares is at least 25 percentage points higher than among parents who report keeping their children up to date on recommended childhood vaccines, a relationship that remains significant even when controlling for factors like age, education, and partisanship. 

Bar chart showing the percentage of parents who believe four false vaccine claims are definitely or probably true, broken down by total parents and by whether they have skipped or delayed their children's vaccines or kept them up to date.

Digging Deeper on The Malleable Middle: Patterns of Belief Across Vaccine Myths

While KFF polling has routinely found that at least half the public fall in the “malleable middle” when it comes to a wide variety of false health claims, there are nuances within this group that can be examined by looking at patterns of belief across multiple myths rather than examining a single question.

This new typology identified five groups based off patterns of belief across the four false vaccine claims included in this survey:

  • Consistent myth believers (1% of the public) say all four vaccine myths are true, including at least three out of four as “definitely true.”
  • Leaned myth believers (6% of the public) say all four vaccine myths are true but are somewhat uncertain in their beliefs, saying at least two of the four myths are “probably true.”
  • The mixed middle (31% of the public) provide a range of true and false responses and at least half of the time provide a “probably” response (in either the true or false direction).
  • Leaned myth deniers (26% of the public) say all four vaccine myths are false but are somewhat uncertain, saying at least two of the four myths are “probably false.”
  • Consistent myth deniers (29% of the public) say all four vaccine myths are false, including at least three out of four as “definitely false.”

The “mixed middle” group, making up 31% of all adults, reflects a portion of the “malleable middle” that expresses the most uncertainty and does not routinely land on one side when it comes to commonly circulating vaccine falsehoods. The share who fall in the “mixed middle” differs by partisanship, education, race and ethnicity, and age. For example, four in ten Hispanic adults and about a third (35%) of Black adults are part of this group compared to fewer than three in ten white adults (28%). Republicans (44%) are more than twice as likely as Democrats (18%) to be part of this group, while independents (31%) fall in between the two. Those without a college degree (36%) are also 10 percentage points more likely than college graduates (23%) to fall into this mixed middle group. These findings suggest these groups who disproportionately fall in the “mixed middle” may be an important focus for those looking to counter vaccine misinformation and dispel confusion. 

Stacked bar chart showing the percentage of adults who fall into five belief categories — consistent myth believers, leaned myth believers, the mixed middle, leaned myth deniers, and consistent myth deniers — across four vaccine-related myths, broken down by total adults, total parents, age, race and ethnicity, party identification, and education.

Adults who are frequently using social media for health advice are also more likely to lack certainty across vaccine myths, providing a range of mixed answers and saying at least half of the four myths are either “probably true” or “probably false.” When looking at belief across different vaccine myths, adults who report using social media for health information on at least a weekly basis are twice as likely to fall in the “mixed middle” group as those who never use social media for health (41% v. 21%). Adults who use AI tools for health information at least occasionally are also somewhat more likely to fall into the “mixed middle” compared to those who never use AI for health, but the difference is smaller for AI than it is for social media use.

Stacked bar chart showing the percentage of adults who fall into five belief categories — consistent myth believers, leaned myth believers, the mixed middle, leaned myth deniers, and consistent myth deniers — across four vaccine-related myths, broken down by how often they use social media and AI tools for health information.

Nearly half (45%) of parentswho have skipped or delayed recommended vaccines for their children fall in this “mixed middle” group, underscoring the connection between confusion, uncertainty and parents’ decisions to forgo recommended vaccines for their children.

Stacked bar chart showing the percentage of parents who fall into five belief categories — consistent myth believers, leaned myth believers, the mixed middle, leaned myth deniers, and consistent myth deniers — across four vaccine-related myths, broken down by total parents and by whether they have skipped or delayed their children's vaccines or kept them up to date.

Methodology

This KFF Tracking Poll on Health Information and Trust was designed and analyzed by public opinion researchers at KFF. The survey was conducted May 7 – 31, 2026, online and by telephone among a nationally representative sample of 2,480 U.S. adults in English (2,407) and Spanish (73).

The sample includes 1,977 who were reached through an address-based sample (ABS) and completed the survey online (1,819) or over the phone (158). An additional 503 respondents were reached through a random digit dial telephone (RDD) sample of prepaid (pay-as-you-go) cell phone numbers. Among this prepaid cell phone component, 223 were interviewed by phone and 280 were invited to the web survey via short message service (SMS). Marketing Systems Groups (MSG) provided both the ABS and RDD samples. All fieldwork was managed by SSRS of Glen Mills, PA; sampling design and weighting was done in collaboration with KFF.

Both the ABS and RDD sample frames included disproportionate stratification aimed at reaching Hispanic and non-Hispanic Black respondents. The ABS was also stratified based on model-based prediction of household-members’ party identification (Republican, Democratic, or independent).

Respondents received a $15 incentive for their participation, with interviews completed by phone receiving a mailed check and web respondents receiving an electronic gift card incentive.

In order to ensure data quality, cases were removed if they failed two or more quality checks: (1) attention check questions in the online version of the questionnaire, (2) had over 30% item nonresponse, or (3) had a length less than one quarter of the mean length by mode. Likewise, cases that were reached through ABS who reported a living in a different state than the sampled address were removed for quality assurance. Based on this criterion, 39 cases were removed.

The combined ABS and cell phone samples were weighted to match the sample’s demographics to the national U.S. adult population using data from the Census Bureau’s 2025 Current Population Survey (CPS). The combined sample was weighted by gender by age, gender by education, age by education, race/ethnicity by education, education, race, census region, population density, frequency of internet usage, recalled 2024 vote by quintiles of the county-level 2024 vote share. The weights also take into account differences in the probability of selection for each sample type (ABS and prepaid cell phone). This includes adjustment for the sample design and geographic stratification of the samples, and within household probability of selection. The population density benchmark was from the 2026 Claritas Pop-Facts Premier. The internet frequency benchmarks was from the 2025 National Public Opinion Reference Survey (NPORS) data. The county-level 2024 vote share was from CNN-provided file of 2024 election results by county

The margin of sampling error including the design effect for the full sample is plus or minus 3 percentage points. Numbers of respondents and margins of sampling error for key subgroups are shown in the table below. For results based on other subgroups, the margin of sampling error may be higher. Sample sizes and margins of sampling error for other subgroups are available by request. Sampling error is only one of many potential sources of error and there may be other unmeasured error in this or any other public opinion poll. The following questions included in this survey were designed, analyzed, and paid for by KFF. The demographic questions included in this study were developed and funded jointly by CNN and KFF, with each organization having independent editorial control over its portion of the survey. KFF Public Opinion and Survey Research is a charter member of the Transparency Initiative of the American Association for Public Opinion Research.

GroupN (unweighted)M.O.S.E.
Total2,480± 3 percentage points
   
Race/Ethnicity  
White, non-Hispanic                                                                                       1,355± 3 percentage points
Black, non-Hispanic435± 6 percentage points
Hispanic420± 7 percentage points
   
Age  
18-29399± 7 percentage points
30-49888± 4 percentage points
50-64590± 5 percentage points
65+556± 6 percentage points
   
Party ID  
Democrats774± 5 percentage points
Independents876± 5 percentage points
Republicans607± 5 percentage points
   
Parents of children under 18682± 5 percentage points

Cost and Utilization of Inpatient Mental Health and Substance Use Treatment

Published: Jun 29, 2026

Inpatient treatment for mental health and substance use accounted for 10% of total commercial inpatient stays in 2023 (or 32 per 10,000 enrollees). The average (mean) total inpatient cost (including the share paid by the insurer and the share paid by the patient) for a mental health admission was $15,900 and for a substance use admission was $15,500.

Using claims data from the 2023 Merative MarketScan Commercial Claims Database, this Peterson-KFF analysis describes the most common diagnoses for inpatient treatment and total associated costs, including patients’ out-of-pocket share.

This brief is available through the Peterson-KFF Health System Tracker, an online information hub dedicated to monitoring and assessing the performance of the U.S. health system.

News Release

Nearly Four Million Medicare Beneficiaries Could Be Eligible for the Temporary Medicare GLP-1 Bridge Program Covering These Drugs for Weight Loss

Published: Jun 29, 2026

A new KFF analysis finds that 3.8 million Medicare beneficiaries met the criteria to be eligible for the new Medicare GLP-1 Bridge, based on claims data from 2023.

The temporary 18-month program, launching on July 1 and running through December 2027, will provide coverage of three GLP-1s (Wegovy, Zepbound, and Foundayo) used for weight reduction and weight management to eligible beneficiaries who are enrolled in Medicare Part D.

The total cost to the federal government of the program will depend in part on what share of eligible beneficiaries participate, how quickly they take up coverage, and how many prescriptions each participating beneficiary fills during the 18-month period.

Based on the estimated 3.8 million Part D enrollees eligible, if 10% to 25% participate in Bridge beginning in July 2026 and fill a prescription each month for the duration of the program, the cost to Medicare would be $1.3 billion to $3.3 billion (at a net monthly cost of $245 minus the $50 beneficiary copay). If participation instead ranged from 50% to 75%, the cost to Medicare would be between $6.7 billion and $10 billion.

The clinical criteria for determining a Part D enrollee’s eligibility for Bridge include having a BMI of 35 or more; or having a BMI of 27 or more along with certain comorbid conditions. In addition, eligibility is limited to Part D enrollees who don’t have conditions treated by GLP-1 drugs that are currently covered under Part D, such as type 2 diabetes, and who have not filled a GLP-1 prescription in their Part D plan in 2026.

Although more than 13 million Medicare beneficiaries met the BMI thresholds for obesity or overweight based on diagnosis data in 2023, the analysis shows that a smaller group –9.7 million beneficiaries — were enrolled in Part D and met the clinical criteria for the Medicare-GLP-1 Bridge, and an even smaller subset — 3.8 million – met all of the eligibility criteria. That is because the potentially eligible population for Bridge is not as broad as if the program were targeted to all Medicare beneficiaries with obesity or overweight.

Tennessee Plans to Share Data on Children with Disabilities with Immigration Authorities

Published: Jun 29, 2026

According to recent news reports, the families of about 400 children with disabilities who are enrolled in Tennessee’s Children’s Special Services (CSS) program received notices from the state health department in early June stating that if their child continued to remain enrolled in CSS beyond June 30, 2026, their information would be reported to a central state immigration enforcement agency. However, following a lawsuit filed by physicians in the state, a judge issued a temporary restraining order on June 24, 2026, to prevent this data sharing from taking place. Tennessee is one of at least six states that have taken actions as of June 2026 to require state agencies to report applicants or recipients of Medicaid and/or other public benefits whose immigration status could not be verified and/or who were verified to not have lawful presence with immigration enforcement authorities. Under longstanding federal law, Medicaid and other federally funded health coverage are already limited to lawfully present immigrants.

In Tennessee, the legislation requires every state governmental entity, local governmental entity, and local health department to verify that each applicant who is 18 years of age or older and applies for a federal, state, or local public benefit is a United States citizen or lawfully present immigrant. It also requires these entities to report all identifying information for individuals who are not lawfully present and who receive federal, state, or local public benefits to the state’s centralized immigration enforcement division and makes it a criminal offense for an employee or official to intentionally fail to report an individual who is not lawfully present.

Tennessee has interpreted this law to include its CSS program, although Tennessee Representative Steve Cohen wrote a letter to Governor Bill Lee indicating that the law reads as limited to applicants who are at least 18 years old. Tennessee’s CSS program provides care coordination and payment assistance for certain services to people under age 21 whose family income is at or below 225% of the federal poverty level and who have a physical disability, such as cerebral palsy, cystic fibroses, sickle cell anemia or other serious medical conditions without immigrant eligibility restrictions. A recent report indicates more than 4,600 children in Tennessee are enrolled in CSS.

Health care providers and advocates in the state have warned that this data sharing will likely lead families to stop participating in the program, which could lead to disruptions in care that have life threatening consequences. Reporting requirements could also have “chilling effects” that lead to disenrollment and forgone enrollment among a broader group of families than those subject to the new reporting requirements due to confusion and fear. 

A 2025 national KFF survey shows that the share of immigrant adults who said they avoided applying for a government program that helps pay for food, housing, or health care in the past 12 months because they did not want to draw attention to their or a family member’s immigration status rose from 8% to 12% between 2023 and 2025. Further, 11% of immigrant adults say they have stopped participating in such a program since January 2025 because of immigration-related worries, including about four in ten (42%) of those who are likely undocumented and about one in six (17%) parents. Moreover, about half (51%) of immigrant adults overall and about eight in ten (78%) of those who are likely undocumented said they are “somewhat” or “very” concerned about health officials or providers sharing patient information with immigration enforcement officials (Figure 1). These data were collected prior to recent state-level actions to share data on immigrant families with immigration enforcement officials.

About Half of Immigrant Adults Say That They Are "Very" or "Somewhat" Concerned About Health Care Providers Sharing Patient Information With ICE or Customs and Border Patrol (Stacked Bars)

Beyond the data sharing actions in Tennessee and several other states, in July 2025, the Centers for Medicare and Medicaid Services (CMS) and U.S. Immigration and Customs Enforcement (ICE) established an Information Exchange Agreement that enables immigration enforcement officials to access the personal data of millions of Medicaid enrollees to help identify and locate “aliens in the United States.” This data sharing represents a reversal in prior policy that asserted CMS would not share such information and ICE would not use such information for immigration enforcement purposes, with assurances made to the public, applicants and enrollees, health care providers, and states that information collected to determine eligibility for health coverage programs would not be used for immigration enforcement. The administration also has directed the Internal Revenue Service to share personal information of individuals for immigration enforcement purposes, although these actions are facing court challenges.

Nearly Four Million Medicare Beneficiaries Met the Eligibility Criteria in 2023 for the Medicare GLP-1 Bridge

Published: Jun 29, 2026

On July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will roll out a new, temporary program covering GLP-1s for obesity for people with Medicare. The program, known as the Medicare GLP-1 Bridge, provides coverage of GLP-1s used for weight reduction and weight management to eligible beneficiaries enrolled in Medicare Part D, although the program will operate outside of the Part D benefit and payment system. Under the Medicare GLP-1 Bridge, eligible beneficiaries can get Medicare coverage of GLP-1s for obesity for a $50 monthly copayment, which will not count towards the Part D deductible or out-of-pocket spending cap and Part D Low-Income Subsidy cost-sharing assistance will not apply. The temporary program, running from July 2026 through December 2027, does not change the current statutory prohibition on Medicare coverage of drugs used for weight loss but instead is being established using the federal government’s Section 402 demonstration authority.

The Medicare GLP-1 Bridge will provide coverage of three GLP-1s (Wegovy, Zepbound, and Foundayo) that have been approved by the FDA for chronic weight management in adults with obesity (BMI of 30 or more) or adults with overweight (BMI of 27 or more) plus a weight-related comorbid condition. The clinical criteria for determining eligibility for the Medicare GLP-1 Bridge are somewhat more restrictive than the FDA approvals, however, and include Part D enrollees with a BMI of 35 or more; with a BMI of 30 or more and heart failure with preserved ejection fraction, uncontrolled hypertension, or chronic kidney disease stage 3a or above; or with a BMI of 27 or more and pre-diabetes, previous myocardial infarction, previous stroke, or symptomatic peripheral artery disease.

Eligibility for the Medicare GLP-1 Bridge will also be limited to Medicare beneficiaries who have not filled a prescription under their Part D plan for a GLP-1 in 2026, and who do not have a diagnosis with a condition that is a medically accepted indication for a GLP-1 drug that could be covered under Part D (specified by CMS as type 2 diabetes, obstructive sleep apnea (OSA), and noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH)), even if they otherwise meet the clinical criteria. These limits are designed to prevent GLP-1 use that could be covered under Part D from shifting to the Medicare GLP-1 Bridge and will also help to limit the cost of the program to Medicare. As part of the prior authorization process for Bridge, prescribing clinicians will need to attest that the GLP-1 prescription is for weight reduction and weight management and that beneficiaries meet the clinical criteria and do not have a diagnosis of type 2 diabetes, OSA, or MASH that would make them eligible for GLP-1 coverage under Part D.

CMS has not released an estimate of how many beneficiaries could be eligible for the Medicare GLP-1 Bridge, although the director of Medicare at CMS, Chris Klomp, recently stated the agency anticipates the program will start with “single-digit millions” of beneficiaries. This analysis uses 2023 Medicare claims for traditional Medicare, Medicare Advantage encounter data, and Part D prescription drug event data to estimate the total number of Medicare beneficiaries with obesity or overweight, the number of Part D enrollees who met the Bridge eligibility criteria in 2023, and those who met the Bridge clinical criteria but who also had diagnoses recorded in claims or encounter data that would qualify for Part D coverage of GLP-1s (type 2 diabetes, OSA, or MASH) or who had a GLP-1 Part D-covered prescription during the year, either of which would make them ineligible for Bridge (see Methods).

More than 13 million Medicare beneficiaries met the BMI thresholds for obesity or overweight in 2023, but not all are potentially eligible for the Medicare GLP-1 Bridge. In 2023, an estimated 13.3 million Medicare beneficiaries enrolled in Parts A and B had obesity or overweight, based on having BMI of 27 or more recorded in claims or encounter data, or 24% of Medicare beneficiaries overall (Figure 1). (This estimate could be conservative to the extent that not all beneficiaries with obesity or overweight may have a claims-based diagnosis.) However, the potentially eligible population for the Medicare GLP-1 Bridge is not as broad as if the program were targeted to all people with Medicare with obesity or overweight. As detailed below, an estimated 3.8 million beneficiaries could be eligible for Bridge as of 2023, based on meeting all the eligibility criteria.

More Than 13 Million Medicare Beneficiaries Met the BMI Thresholds for Obesity or Overweight in 2023, But Not All are Potentially Eligible for the Medicare GLP-1 Bridge (Bar Chart)

Among the 47.5 million Medicare Part D enrollees in 2023, 9.7 million enrollees met the clinical criteria for the Medicare GLP-1 Bridge in 2023, but less than half of this group—3.8 million (39%)—is estimated to be eligible for Bridge (Figure 2, Table 1). These 3.8 million Part D enrollees met the clinical criteria, did not have a diagnosis of type 2 diabetes, OSA, or MASH, or a GLP-1 Part D-covered prescription in 2023, and could be eligible for the Medicare GLP-1 Bridge, assuming no changes in diagnosis or GLP-1 use in Part D in 2026. This estimate, which includes Part D enrollees in traditional Medicare and Medicare Advantage, represents 8% of Medicare Part D enrollees and 7% of the total population enrolled in Medicare Part A and Part B for the entire year in 2023. The other 5.9 million Part D enrollees met the clinical criteria but also had claims or encounter data recording a diagnosis of type 2 diabetes, OSA, or MASH, and/or had a GLP-1 Part D-covered prescription, either of which would make them ineligible for Bridge.

In 2023, 3.8 Million Medicare Part D Enrollees Met the Eligibility Criteria for the Medicare GLP-1 Bridge (Donut Chart)

The total cost to the federal government of the Medicare GLP-1 Bridge will depend in part on how many beneficiaries are eligible in 2026 and 2027, what share of them participate, how quickly they initiate use under the program after it begins, and how many prescriptions each participating beneficiary fills during the 18-month period. While take-up is uncertain, interest in the program among potentially eligible Medicare beneficiaries is likely to be strong. Based on the estimated 3.8 million Part D enrollees eligible for the Medicare GLP-1 Bridge as of 2023, if 10% to 25% participate in Bridge from when the program launches in July 2026 and fill a prescription each month for the 18-month duration of the program, the cost to Medicare would be $1.3 billion to $3.3 billion (at a net monthly cost of $245 minus the $50 beneficiary copay). Assuming higher participation rates ranging from 50% to 75%, the cost to Medicare would be between $6.7 billion and $10 billion. The ultimate cost to the federal government of the Medicare GLP-1 Bridge will depend on actual participation numbers and adherence during the 18-month program, as well as potential cost offsets from savings that might accrue over time due to beneficiary health improvements from GLP-1 use for weight reduction and weight management.

Estimated Number of Medicare Part D Enrollees Who Met the Clinical Criteria for the Medicare GLP-1 Bridge in 2023 (Table)

Methods

This analysis mapped ICD-10 codes to the clinical criteria specified by CMS for the Medicare GLP-1 Bridge and utilized the 2023 20% Research Identifiable File (RIF) Medicare Fee-For-Service Claims and Medicare Advantage Encounter Data to create condition flags, along with the Part D Prescription Drug Event data to create a flag for GLP-1 use. The 2023 RIF Master Beneficiary Summary File (Base A/B/C/D file) was used to identify individuals to include in the analysis, which were then weighted to produce population estimates. To be included in the analysis of diagnosis with obesity or overweight, an individual was required to have coverage under Parts A and B for all months of 2023, not have switched between traditional Medicare and Medicare Advantage during the year, and remain living for the entire year. To be included in the Bridge eligibility analysis, an individual was required to have coverage for Parts A, B, and D for all months of 2023, not have switched between traditional Medicare and Medicare Advantage during the year, and remain living for the entire year. Individuals were grouped based on their insurance type (traditional Medicare or Medicare Advantage) for 2023. Individuals received a condition flag if they had one or more claims/encounters that matched a respective ICD-10 code mapped onto one of the Bridge clinical criteria in an inpatient, outpatient, carrier, home health, or skilled nursing facility setting in 2023. Individuals received a GLP-1 user flag if they had one or more Part D prescription drug event claims for a GLP-1 medication in 2023.

Diagnoses on Medicare Advantage chart reviews were not included in the creation of the condition flags. This produces a somewhat more conservative estimate of Medicare Advantage enrollees who could be eligible for the Medicare GLP-1 Bridge.

This work was supported in part by Arnold Ventures. KFF maintains full editorial control over all of its policy analysis, polling, and journalism activities.

Tracking Implementation of the 2025 Reconciliation Law Medicaid Work Requirements

Updated on:

KFF Resources on Medicaid Work Requirements

Work requirements overview:

50-state survey of Medicaid eligibility and enrollment policies:

Medical frailty exemption:

Implementation of work requirements:

Research and analysis on Medicaid and work:

1115 work requirement waivers:

Work requirements implications and state experience:

Arkansas work requirement experience:

KFF Polling on Work Requirements:

Beyond the Data by KFF CEO Drew Altman:

Tracking Implementation of the 2025 Reconciliation Law Medicaid Work Requirements

Updated on:

The 2025 reconciliation law requires states to condition Medicaid eligibility for adults in the ACA Medicaid expansion group on meeting work requirements starting January 1, 2027; however, states have the option to implement requirements sooner through a state plan amendment (SPA) or through an approved 1115 waiver.

State Plan Amendments (SPAs)

States may choose to implement work requirements prior to the required January 1, 2027 implementation date through a state plan amendment. Nebraska is the first state to announce that it will begin enforcing federal work requirements early through a state plan amendment, starting May 1, 2026. Two other states are also planning to implement before January 2027–Montana on July 1, 2026 and Iowa on December 1, 2026. Arkansas has announced that it plans to launch a soft implementation of work requirements on July 1, 2026 but will not disenroll individuals prior to January 1, 2027.

1115 Waivers

Since the start of the second Trump administration, several states have submitted waivers to implement work requirements. However, states are unlikely to be moving forward with proposed 1115 waivers at this time due to the passage of federal work requirements. States that plan to implement federal work requirements early will do so through a state plan amendment. Currently, Georgia is the only state with a Medicaid work requirement waiver in place following litigation over the Biden administration’s attempt to stop it. Georgia’s waiver will expire December 31, 2026; the state is required to come into compliance with the new federal requirements effective January 1, 2027.

Early Implementation and Waiver Status

The map below identifies states that have indicated they will implement federal work requirements early through a state plan amendment and the one state (Georgia) that has implemented work requirements through an 1115 waiver.

States Implementing Work Requirements Early and/or With Approved Work Requirement Waivers (Choropleth map)